Article

Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center Series

2022-03-18

Abstract excerpt

<h4>Background: </h4> Breast cancer (BC) remains the most common cancer in women, and it is the second leading cause of cancer-related death in women. Because of advances in treatment, long life is now possible even in patients with metastatic BC, whereas certain groups of patients survive for a very short time despite being diagnosed at an early stage. In many studies, the triple negative BC subgroup is stated to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b23dcacb-f3bf-5efc-89ad-8191d0bd4f9b
DOI: 10.21203/rs.3.rs-1447957/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center SeriesDOI 10.21203/rs.3.rs-1447957/v1Read

Breast Cancer Subtypes And Prognosis: Answers To Subgroup Classification Questions, Identifying The Worst Subgroup In Our Single-Center SeriesSemantic proximity Read

Update on triple‐negative breast cancers – highlighting subtyping update and treatment implicationSemantic proximity Read

Clinicopathological features and prognosis of HER2 low-expression breast cancer: a single-center retrospective studySemantic proximity Read

The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtypeSemantic proximity Read

Triple negative breast cancer: looking for the missing link between biology and treatments.Semantic proximity Read

Targeting basal-like breast cancers.Semantic proximity Read

Histopathological and Clinical Features of HER2-Positive Breast Cancers across Hormone Receptor Subgroups: A Cross-Sectional AnalysisSemantic proximity Read

Is the differentiation into molecular subtypes of breast cancer important for staging, local and systemic therapy, and follow up?Semantic proximity Read

Response-based molecular subtyping—emergence of the third generation of breast cancer subtypesSemantic proximity Read

Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer - one clinic experience.Semantic proximity Read

The hormone receptor status in breast cancer and the relationship of subtypes with clinicopathological features.Semantic proximity Read

The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER-/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute.Semantic proximity Read